Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of amsulosin + ginseng versus tamsulosin + licorice for benign prostatic hyperplasia symptoms
IRCT20151123025202N44Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin, ginseng and glycyrrhiza glabra in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
tamsulosinginsengglycyrrhiza glabra
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20151123025202N44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151123025202N44.